Emerging biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) announced on Wednesday the acquisition of privately-held Californian company ERS Holdings, LLC, via a binding letter of intent. ERS holds the patent for “RTIC” technology, which stands for Ready to Infuse Cannabis, as well as several other patents for processes to convert cannabis oil into powder to infuse it into various food and beverage products. Such products include capsules, K-Cups, liquid shots, protein shakes, lotions and bottled beverages.
Who Are Pivot Pharmaceuticals?
The company touts itself as a biopharmaceutical firm focused on finding commercial avenues for therapeutic pharmaceuticals and nutraceuticals through the use of drug delivery platform technologies. Central to their mission is research and development work that examines cannabinoid-based nutraceuticals and pharmaceuticals.
Like most companies of their stature, Pivot’s performs research through a wholly-owned subsidiary; theirs being a medical cannabis products division called Pivot Green Stream Health Solutions Inc. To-date, the